Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 159 (11), 1185-94

The Challenge of Drug-Induced Aseptic Meningitis

Affiliations
Review

The Challenge of Drug-Induced Aseptic Meningitis

G Moris et al. Arch Intern Med.

Abstract

Several drugs can induce the development of aseptic meningitis. Drug-induced aseptic meningitis (DIAM) can mimic an infectious process as well as meningitides that are secondary to systemic disorders for which these drugs are used. Thus, DIAM constitutes a diagnostic and patient management challenge. Cases of DIAM were reviewed through a MEDLINE literature search (up to June 1998) to identify possible clinical and laboratory characteristics that would be helpful in distinguishing DIAM from other forms of meningitis or in identifying a specific drug as the culprit of DIAM. Our review showed that nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, intravenous immunoglobulins, and OKT3 antibodies (monoclonal antibodies against the T3 receptor) are the most frequent cause of DIAM. Resolution occurs several days after drug discontinuation and the clinical and cerebrospinal fluid profile (neutrophilic pleocytosis) do not allow DIAM to be distinguished from infectious meningitis. Nor are there any specific characteristics associated with a specific drug. Systemic lupus erythematosus seems to predispose to NSAID-related meningitis. We conclude that a thorough history on prior drug intake must be conducted in every case of meningitis, with special focus on those aforementioned drugs. If there is a suspicion of DIAM, a third-generation cephalosporin seems a reasonable treatment option until cerebrospinal fluid cultures are available.

Comment in

Similar articles

  • Drug-induced Aseptic Meningitis
    S Hopkins et al. Expert Opin Drug Saf 4 (2), 285-97. PMID 15794720. - Review
    Drug-induced aseptic meningitis (DIAM) is an important entity. This article reviews the literature on this rare idiosyncratic event which may occur after local or systemi …
  • Drug-induced Aseptic Meningitis in Suspected Central Nervous System Infections
    L Kepa et al. J Clin Neurosci 12 (5), 562-4. PMID 16051094. - Case Reports
    This study presents eight patients with drug-induced aseptic meningitis (DIAM) admitted to our centre with an initial suspicion of central nervous system (CNS) infection. …
  • Drug-induced Aseptic Meningitis
    E Nettis et al. Curr Drug Targets Immune Endocr Metabol Disord 3 (2), 143-9. PMID 12769786. - Review
    Aseptic meningitis is a rare but well-recognized complication of drug therapy. The clinical presentation of drug-induced aseptic meningitis (DIAM) is distinct. Symptoms t …
  • Drug-induced Aseptic Meningitis: Diagnosis and Management
    S Jolles et al. Drug Saf 22 (3), 215-26. PMID 10738845. - Review
    Drug-induced aseptic meningitis (DIAM) has been reported as an uncommon adverse reaction with numerous agents. It is a diagnosis of exclusion, and clinical signs and CSF …
  • Drug-induced Aseptic Meningitis: A Mini-Review
    M Yelehe-Okouma et al. Fundam Clin Pharmacol 32 (3), 252-260. PMID 29364542. - Review
    Aseptic meningitis associates a typical clinical picture of meningitis with the absence of bacterial or fungal material in the cerebrospinal fluid. Drug-induced aseptic m …
See all similar articles

Cited by 24 PubMed Central articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback